Search hospitals > Ohio > Delaware
Delaware Radiation Oncology
Claim this profileDelaware, Ohio 43015
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
113 reported clinical trials
2 medical researchers
Summary
Delaware Radiation Oncology is a medical facility located in Delaware, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Delaware Radiation Oncology is involved with conducting 113 clinical trials across 295 conditions. There are 2 research doctors associated with this hospital, such as Timothy D. Moore and John P. Kuebler.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
John P. KueblerStrecker Cancer Center-Belpre12 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Carcinoma
1 reported clinical trial
5 drugs studied
Clinical Trials running at Delaware Radiation Oncology
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Meningioma
ALK Gene Rearrangement
Cancer
Neurofibromatosis
Colorectal Cancer
Adenoma
Progesterone Receptor Positive
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Delaware Radiation Oncology?
Delaware Radiation Oncology is a medical facility located in Delaware, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Delaware Radiation Oncology is involved with conducting 113 clinical trials across 295 conditions. There are 2 research doctors associated with this hospital, such as Timothy D. Moore and John P. Kuebler.